ERIS.BO | Eris Lifesciences Limited Annual & Quarterly

Annual Balance Sheets

(In INR)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	70.48 Billion	36.67 Billion	22.72 Billion	18.34 Billion	15.52 Billion	15.53 Billion
Total Current Assets	23.02 Billion	7.64 Billion	6.27 Billion	4.67 Billion	4.79 Billion	5.81 Billion
Cash And Short Term Investments	14 Billion	860.29 Million	2.12 Billion	935.02 Million	1 Billion	3.22 Billion
Cash and Cash Equivalents	14 Billion	560.22 Million	508.7 Million	368.25 Million	672.11 Million	75 Million
Short Term Investments	20 Thousand	300.07 Million	1.61 Billion	566.77 Million	333.58 Million	3.14 Billion
Net Receivables	4.27 Billion	4.59 Billion	2.08 Billion	1.73 Billion	2.07 Billion	1.37 Billion
Inventory	1.89 Billion	1.31 Billion	1.17 Billion	944.66 Million	694.75 Million	826.53 Million
Other Current Assets	2.84 Billion	2.47 Billion	1.06 Billion	450 Thousand	91.28 Million	6.47 Million
Total Non-Current Assets	47.46 Billion	29.02 Billion	16.44 Billion	13.67 Billion	10.72 Billion	9.71 Billion
Net PPE	5.23 Billion	3.77 Billion	1.91 Billion	778.78 Million	872.43 Million	560.71 Million
Good Will And Intangible Assets	38.23 Billion	22.12 Billion	7.53 Billion	7.77 Billion	7.91 Billion	7.07 Billion
Good Will	8.61 Billion	3.31 Billion	934.74 Million	934.74 Million	934.74 Million	935.87 Million
Intangible Assets	29.62 Billion	18.8 Billion	6.59 Billion	6.84 Billion	6.98 Billion	6.13 Billion
Long-Term Investments	259.14 Million	128.41 Million	4.23 Billion	2.9 Billion	90.61 Million	467.94 Million
Tax Assets	3.06 Billion	2.73 Billion	2.43 Billion	2 Billion	1.7 Billion	1.44 Billion
Other Non Current Assets	667.18 Million	259.97 Million	330.82 Million	208.1 Million	135.3 Million	170.29 Million
Other Assets	-	0.00	-	-	-	-
Total Liabilities	38.26 Billion	14.46 Billion	3.63 Billion	2.58 Billion	2.55 Billion	3.84 Billion
Total Current Liabilities	25.32 Billion	4.43 Billion	1.99 Billion	1.66 Billion	1.64 Billion	3.05 Billion
Account Payables	2.68 Billion	1.24 Billion	1.17 Billion	1.02 Billion	1 Billion	841.25 Million
Tax Payables	395.9 Million	39 Million	69.97 Million	77.51 Million	69.98 Million	18.11 Million
Short Term Debt	20.89 Billion	1.93 Billion	40.13 Million	23.3 Million	59.99 Million	1.76 Billion
Deferred Revenue	395.9 Million	33.35 Million	38.71 Million	28.93 Million	24.84 Million	26.16 Million
Other Current Liabilities	1.34 Billion	1.21 Billion	739.88 Million	590.92 Million	561.56 Million	426.66 Million
Total Non Current Liabilities	12.94 Billion	10.03 Billion	1.64 Billion	914.26 Million	912.81 Million	792.96 Million
Long-Term Debt	6.54 Billion	6.83 Billion	803.94 Million	44.47 Million	61.44 Million	2.93 Million
Deferred Revenue Non Current	370.18 Million	87.39 Million	56.88 Million	61.11 Million	85.45 Million	66.63 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	603.85 Million	536.2 Million	321.14 Million	313.3 Million	259.77 Million	206.45 Million
Other Liabilities	1.00	-	-	-	-	-
Total Equity	32.22 Billion	22.2 Billion	19.08 Billion	15.76 Billion	12.96 Billion	11.68 Billion
Stock Holders Equity	25.86 Billion	21.95 Billion	19.08 Billion	15.76 Billion	12.96 Billion	11.5 Billion
Common Stock	136.03 Million	135.99 Million	135.93 Million	135.78 Million	135.78 Million	137.52 Million
Retained Earnings	25.49 Billion	21.55 Billion	18.73 Billion	15.5 Billion	12.79 Billion	11.33 Billion
Accumulated other comprehensive income	25.72 Billion	287 Million	242.06 Million	135.78 Million	135.78 Million	151.01 Million
Common Stock Equity	25.86 Billion	21.95 Billion	19.08 Billion	15.76 Billion	12.96 Billion	11.5 Billion
Capital Lease Obligation	370.19 Million	466.95 Million	393.96 Million	67.67 Million	121.43 Million	-
Total Investments	259.16 Million	68.77 Million	4.2 Billion	2.85 Billion	32.04 Million	409.12 Million
Total Debt	27.81 Billion	8.76 Billion	844.07 Million	67.77 Million	121.43 Million	1.76 Billion
Net Debt	13.8 Billion	8.2 Billion	335.37 Million	-300.48 Million	-550.68 Million	1.68 Billion

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	70.21 Billion	-	70.48 Billion	70.48 Billion	-	38.75 Billion
Total Current Assets	13.17 Billion	14 Billion	23.02 Billion	23.02 Billion	1.9 Billion	9.61 Billion
Cash And Short Term Investments	2.46 Billion	14 Billion	14 Billion	14 Billion	1.9 Billion	1.92 Billion
Cash and Cash Equivalents	1.5 Billion	-14 Billion	14 Billion	14 Billion	-1.9 Billion	1.72 Billion
Short Term Investments	964 Million	28.01 Billion	20 Thousand	20 Thousand	3.81 Billion	195.2 Million
Net Receivables	5.67 Billion	-	4.27 Billion	4.27 Billion	-	3.54 Billion
Inventory	2.56 Billion	-	1.89 Billion	1.89 Billion	-	1.39 Billion
Other Current Assets	8.14 Billion	-	2.84 Billion	2.84 Billion	-	2.74 Billion
Total Non-Current Assets	57.04 Billion	-14 Billion	47.46 Billion	47.46 Billion	-1.9 Billion	29.14 Billion
Net PPE	5.2 Billion	-	5.23 Billion	5.23 Billion	-	4.22 Billion
Good Will And Intangible Assets	47.81 Billion	-	38.23 Billion	38.23 Billion	-	21.55 Billion
Good Will	8.94 Billion	-	8.61 Billion	8.61 Billion	-	3.31 Billion
Intangible Assets	38.87 Billion	-	29.62 Billion	29.62 Billion	-	18.23 Billion
Long-Term Investments	531.5 Million	-	259.14 Million	259.14 Million	-	152.89 Million
Tax Assets	2.89 Billion	-	3.06 Billion	3.06 Billion	-	2.95 Billion
Other Non Current Assets	598.2 Million	-14 Billion	667.18 Million	667.18 Million	-1.9 Billion	257.26 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	38.44 Billion	-32.22 Billion	38.26 Billion	38.26 Billion	-	14.47 Billion
Total Current Liabilities	12.34 Billion	-	25.32 Billion	25.32 Billion	-	4.97 Billion
Account Payables	2.81 Billion	-	2.68 Billion	2.68 Billion	-	1.5 Billion
Tax Payables	338 Million	-	395.9 Million	395.9 Million	-	137.96 Million
Short Term Debt	7.28 Billion	-	20.89 Billion	20.89 Billion	-	1.97 Billion
Deferred Revenue	338 Million	-	395.9 Million	395.9 Million	-	1.27 Billion
Other Current Liabilities	1.9 Billion	-	1.34 Billion	1.34 Billion	-	221.38 Million
Total Non Current Liabilities	26.1 Billion	-32.22 Billion	12.94 Billion	12.94 Billion	-	9.5 Billion
Long-Term Debt	19.66 Billion	-	6.54 Billion	6.54 Billion	-	6.32 Billion
Deferred Revenue Non Current	313.1 Million	-	370.18 Million	370.18 Million	-	536.1 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	851.9 Million	-32.22 Billion	603.85 Million	603.85 Million	-	110.9 Million
Other Liabilities	-	-	1.00	1.00	-	-
Total Equity	31.77 Billion	32.22 Billion	32.22 Billion	32.22 Billion	24.27 Billion	24.27 Billion
Stock Holders Equity	27.71 Billion	32.22 Billion	25.86 Billion	25.86 Billion	24.27 Billion	24.11 Billion
Common Stock	136 Million	-	136.03 Million	136.03 Million	-	136.02 Million
Retained Earnings	-	-	25.49 Billion	25.49 Billion	-	-
Accumulated other comprehensive income	-	25.86 Billion	25.72 Billion	51.45 Billion	24.11 Billion	136.02 Million
Common Stock Equity	27.71 Billion	32.22 Billion	25.86 Billion	25.86 Billion	24.27 Billion	24.11 Billion
Capital Lease Obligation	395.9 Million	-	370.19 Million	370.19 Million	-	436.05 Million
Total Investments	520.9 Million	28.01 Billion	259.16 Million	259.16 Million	3.81 Billion	142.86 Million
Total Debt	26.95 Billion	-	27.81 Billion	27.81 Billion	-	8.29 Billion
Net Debt	25.45 Billion	14 Billion	13.8 Billion	13.8 Billion	1.9 Billion	6.56 Billion

Balance Sheet Charts

PT Aneka Tambang Tbk

PAEKY

Full Analysis

Annual Balance Sheets
VentriPoint Diagnostics Ltd.

VPT

Full Analysis

Annual Balance Sheets
Fluidomat Limited

FLUIDOM

Full Analysis

Annual Balance Sheets
Kuuhubb Inc.

BCDMF

Full Analysis

Annual Balance Sheets
Telecanor Global Limited

TELECANOR

Full Analysis

Annual Balance Sheets
AddLife AB (publ)

0REZ

Full Analysis

Annual Balance Sheets

Global Stocks Search

Eris Lifesciences Limited (ERIS.BO)

Annual Balance Sheets

Balance Sheet Charts

PT Aneka Tambang Tbk

VentriPoint Diagnostics Ltd.

Fluidomat Limited

Kuuhubb Inc.

Telecanor Global Limited

AddLife AB (publ)